defenage

Defenage sells physician-dispensed, anti-aging skin-care formulas centered on its patented Age-Repair Defensins technology. The line is small and focused—three core treatment creams (8-in-1 BioSerum, 24/7 Barrier Balance, 6-Week Perfection Neck) plus complementary cleansers, masks, and SPF that retail between $42 and $198. Distribution is strictly professional: the brand is sold only through certified dermatology, plastic-surgery, and medical-spa practices, with fulfillment via the brand’s password-protected clinician portal and its consumer-facing e-commerce site that verifies physician referral. The company’s scientific point of difference is the use of lab-synthesized alpha-defensin 5 and beta-defensin 3 peptides that awaken dormant LGR6+ stem cells in the skin, a mechanism the brand calls “dermatologist-directed skin regeneration.” Clinical data published in peer-reviewed journals show up to 14 years’ visible age reversal in 6 weeks, a claim that underpins the cult status of the 8-in-1 BioSerum. All formulas are fragrance-free, hydroquinone-free, and produced in small, stability-tested U.S. batches packaged in airless pumps to preserve peptide activity. The core buyer is 35-65, skincare-savvy, and willing to pay medical-grade prices for evidence-based results without injectables or downtime; many are existing patients already receiving lasers, microneedling, or neurotoxins. These consumers value physician oversight, clean ingredient lists, and high-performance science over luxury packaging or celebrity marketing. Defenage competes in the professional, regenerative skincare tier against brands leveraging growth factors, exosomes, or retinoids; it differentiates by offering a defensin-exclusive pathway that bypasses irritation and sun restrictions. Its closed medical-channel strategy reinforces clinical credibility, while a concise SKU count simplifies retailing for practitioners and signals focused efficacy to patients comparing crowded multi-step regimens.